Search Results - "Golovics, Petra"

Epidemiology, Treatment Strategy, Natural Disease Course and Surgical Outcomes of Patients with Ulcerative Colitis in Western Hungary – A Population-based Study Between 2007 and 2018: Data from the Veszprem County Cohort by Kurti, Zsuzsanna, Gonczi, Lorant, Lakatos, Laszlo, Golovics, Petra A, Pandur, Tunde, David, Gyula, Erdelyi, Zsuzsanna, Szita, Istvan, Lakatos, Peter L

“…Abstract Background and Aims The number of population-based studies in ulcerative colitis [UC] from Eastern Europe is limited. Our aim here was to analyse the…”
Get full text

Incidence, Prevalence, Disease Course, and Treatment Strategy of Crohn's Disease Patients from the Veszprem Cohort, Western Hungary: A Population-based Inception Cohort Study Between 2007 and 2018 by Gonczi, Lorant, Lakatos, Laszlo, Kurti, Zsuzsanna, Golovics, Petra A, Pandur, Tunde, David, Gyula, Erdelyi, Zsuzsanna, Szita, Istvan, Lakatos, Peter L

“…The number of prospective population-based studies on Crohn's disease[CD] is still limited from Eastern Europe. The present study is a continuation of the…”
Get full text

Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades – Results from a population‐based study over four decades by Gonczi, Lorant, Lakatos, Laszlo, Golovics, Petra A., Angyal, Dorottya, Balogh, Fruzsina, Ilias, Akos, Pandur, Tunde, David, Gyula, Erdelyi, Zsuzsanna, Szita, Istvan, Lakatos, Peter L.

“…Summary Background Few population‐based studies have investigated the prevalence and disease course of perianal manifestation in Crohn's disease. Aims To…”
Get full text

Prospective, Multicentre, Nationwide Clinical Data from 600 Cases of Acute Pancreatitis by Párniczky, Andrea, Kui, Balázs, Szentesi, Andrea, Balázs, Anita, Szűcs, Ákos, Mosztbacher, Dóra, Czimmer, József, Sarlós, Patrícia, Bajor, Judit, Gódi, Szilárd, Vincze, Áron, Illés, Anita, Szabó, Imre, Pár, Gabriella, Takács, Tamás, Czakó, László, Szepes, Zoltán, Rakonczay, Zoltán, Izbéki, Ferenc, Gervain, Judit, Halász, Adrienn, Novák, János, Crai, Stefan, Hritz, István, Góg, Csaba, Sümegi, János, Golovics, Petra, Varga, Márta, Bod, Barnabás, Hamvas, József, Varga-Müller, Mónika, Papp, Zsuzsanna, Sahin-Tóth, Miklós, Hegyi, Péter

“…The aim of this study was to analyse the clinical characteristics of acute pancreatitis (AP) in a prospectively collected, large, multicentre cohort and to…”
Get full text

Stable Incidence and Risk Factors of Colorectal Cancer in Ulcerative Colitis: A Population-Based Cohort Between 1977–2020 by Wetwittayakhlang, Panu, Golovics, Petra A., Gonczi, Lorant, Lakatos, Laszlo, Lakatos, Peter L., Kurti, Zsuzsanna, David, Gyula, Erdelyi, Zsuzsanna, Szita, Istvan, Pandur, Tunde, Al Khoury, Alex

Get full text

Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years by Barkai, Laszlo J., Gonczi, Lorant, Balogh, Fruzsina, Angyal, Dorottya, Farkas, Klaudia, Farkas, Bernadett, Molnar, Tamas, Szamosi, Tamas, Schafer, Eszter, Golovics, Petra A., Juhasz, Mark, Patai, Arpad, Vincze, Aron, Sarlos, Patricia, Farkas, Alexandra, Dubravcsik, Zsolt, Toth, Tamas G., Szekely, Hajnal, Miheller, Pal, Lakatos, Peter L., Ilias, Akos

“…Long-term data on ustekinumab in real-life Crohn’s disease patients are still missing, though randomized controlled trials demonstrated it as a favorable…”
Get full text

Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease by Wetwittayakhlang, Panu, Albader, Farah, Golovics, Petra A, Hahn, Gustavo Drügg, Bessissow, Talat, Bitton, Alain, Afif, Waqqas, Wild, Gary, Lakatos, Peter L

“…Background and Aims. The impact of COVID-19 has been of great concern in patients with inflammatory bowel disease (IBD) worldwide, including an increased risk…”
Get full text

Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease – a prospective, multicentre study by Lontai, Livia, Gonczi, Lorant, Balogh, Fruzsina, Komlodi, Nora, Resal, Tamas, Farkas, Klaudia, Molnar, Tamas, Miheller, Pal, Golovics, Petra A., Schafer, Eszter, Szamosi, Tamas, Ilias, Akos, Lakatos, Peter L.

“…Clinical data on the efficacy and safety of non-medical switch between adalimumab(ADA) biosimilars are limited. The aim of this study was to evaluate…”
Get full text

Declining Trends of Reoperations and Disease Behaviour Progression in Crohn’s Disease over Different Therapeutic Eras—A Prospective, Population-Based Study from Western Hungary between 1977–2020, Data from the Veszprem Cohort by Gonczi, Lorant, Lakatos, Laszlo, Golovics, Petra A, Ilias, Akos, Pandur, Tunde, David, Gyula, Erdelyi, Zsuzsanna, Szita, Istvan, Al Khoury, Alex, Lakatos, Peter L

“…Abstract Background and Aims Few population-based studies have investigated long-term surgery rates for Crohn’s disease [CD]. Our aim was to analyse disease…”
Get full text

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort by Gonczi, Lorant, Gecse, Krisztina B, Vegh, Zsuzsanna, Kurti, Zsuzsanna, Rutka, Mariann, Farkas, Klaudia, Golovics, Petra A, Lovasz, Barbara D, Banai, Janos, Bene, Laszlo, Gasztonyi, Bea, Kristof, Tunde, Lakatos, Laszlo, Miheller, Pal, Nagy, Ferenc, Palatka, Karoly, Papp, Maria, Patai, Arpad, Salamon, Agnes, Szamosi, Tamas, Szepes, Zoltan, Toth, Gabor T, Vincze, Aron, Szalay, Balazs, Molnar, Tamas, Lakatos, Peter L

“…It has been previously shown that biosimilar infliximab CT-P13 is effective and safe in inducing remission in inflammatory bowel diseases. We report here the…”
Get full text

High‐sensitivity C‐reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: A marker for patient classification? by Sandor Kiss, Lajos, Papp, Maria, Dorottya Lovasz, Barbara, Vegh, Zsuzsanna, Anna Golovics, Petra, Janka, Eszter, Varga, Eva, Szathmari, Miklos, Lakatos, Peter Laszlo

“…Background: C‐reactive protein (CRP) is a traditional nonspecific marker of inflammation, with Crohn's disease (CD) being associated with a strong CRP…”
Get full text

Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis by Farkas, Klaudia, Rutka, Mariann, Golovics, Petra A., Végh, Zsuzsanna, Lovász, Barbara D., Nyári, Tibor, Gecse, Krisztina B., Kolar, Martin, Bortlik, Martin, Duricova, Dana, Machkova, Nadezda, Hruba, Veronika, Lukas, Martin, Mitrova, Katarina, Malickova, Karin, Bálint, Anita, Nagy, Ferenc, Bor, Renáta, Milassin, Ágnes, Szepes, Zoltán, Palatka, Károly, Lakatos, Péter L., Lukas, Milan, Molnár, Tamás

“…Introduction: CT-P13 is the first biosimilar to infliximab that has been approved for the same indications as its originator infliximab. No data are available…”
Get full text

Inflammatory bowel disease course in Crohn’s disease:Is the natural history changing? by Golovics, Petra A, Mandel, Michael D, Lovasz, Barbara D, Lakatos, Peter L

“…Crohn’s disease(CD)is a multifactorial potentially debilitating disease.It has a variable disease course,but the majority of patients eventually develop…”
Get full text

Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab – A prospective, multicenter cohort from Hungary by Gonczi, Lorant, Szanto, Kata, Farkas, Klaudia, Molnar, Tamas, Szamosi, Tamas, Schafer, Eszter, Golovics, Petra A., Barkai, Laszlo, Lontai, Livia, Lovasz, Barbara, Juhasz, Mark, Patai, Arpad, Sarang, Krisztina, Vincze, Aron, Sarlos, Patricia, Farkas, Alexandra, Dubravcsik, Zsolt, Toth, Tamas G., Miheller, Pal, Ilias, Akos, Lakatos, Peter L.

“…Although efficacy of ustekinumab (UST) has been demonstrated through randomized trials, data from real-life prospective cohorts are still limited. Our aim was…”
Get full text

Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort by Lakatos, Peter L, Vegh, Zsuzsanna, Lovasz, Barbara D, David, Gyula, Pandur, Tunde, Erdelyi, Zsuzsanna, Szita, Istvan, Mester, Gabor, Balogh, Mihaly, Szipocs, Istvan, Molnar, Csaba, Komaromi, Erzsebet, Golovics, Petra A, Mandel, Michael, Horvath, Agnes, Szathmari, Miklos, Kiss, Lajos S, Lakatos, Laszlo

“…Previous studies suggest that smoking is an important environmental factor in inflammatory bowel diseases (IBDs), with dichotomous effects in ulcerative…”
Get full text

Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology? by Wetwittayakhlang, Panu, Lontai, Livia, Gonczi, Lorant, Golovics, Petra A., Hahn, Gustavo Drügg, Bessissow, Talat, Lakatos, Peter L.

“…The main therapeutic goal of ulcerative colitis (UC) is to induce and maintain remission to prevent long-term disease progression. Treat-to-target strategies,…”
Get full text

Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database by Kurti, Zsuzsanna, Vegh, Zsuzsanna, Golovics, Petra A, Fadgyas-Freyler, Petra, Gecse, Krisztina B, Gonczi, Lorant, Gimesi-Orszagh, Judit, Lovasz, Barbara D, Lakatos, Peter L

“…Abstract Background Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases associated with a substantial healthcare utilization…”
Get full text

Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012 by Golovics, Petra A, Lakatos, Laszlo, Mandel, Michael D, Lovasz, Barbara D, Vegh, Zsuzsanna, Kurti, Zsuzsanna, Szita, Istvan, Kiss, Lajos S, Pandur, Tunde, Lakatos, Peter L

“…To analyze the prevalence, length and predictors of hospitalization in the biological era in the population-based inception cohort from Veszprem province. Data…”
Get full text

Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease : Final Results From a Prospective, Open-Label, Single-Arm Study by Wetwittayakhlang, Panu, Verdon, Christine, Starr, Michael, Hahn, Gustavo Drugg, Golovics, Petra A, Bessissow, Talat, Afif, Waqqas, Wild, Gary, Bitton, Alain, Lakatos, Peter L

“…Background: Endoscopic healing is a key treatment target in inflammatory bowel disease; few data are available on the clinical and endoscopic efficacy of…”
Get full text

Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study by Wetwittayakhlang, Panu, Golovics, Petra A, Khoury, Alex Al, Ganni, Elie, Hahn, Gustavo Drügg, Cohen, Albert, Wyse, Jonathan, Bradette, Marc, Bessissow, Talat, Afif, Waqqas, Wild, Gary, Bitton, Alain, Lakatos, Peter Laszlo

“…Objective monitoring and effective early treatment using a treat-to-target approach are key to improving therapeutic outcomes in IBD patients. This study aimed…”
Get full text